HJ
Himanshu Jayantbhai Shah
Executive
Other
Browse the full record of transactions filed by Himanshu Jayantbhai Shah, Executive. Insider active across 1 company, notably Eris Lifesciences Limited. Aggregated, 14 filings have been recorded. Activity tracked since 19 May 2021. The latest transaction was disclosed on 8 November 2021 (Sale). Regulator: SEBI (PIT + SAST). The full history is free.
Declarations14 total
10,249 shares@ ₹819.52991.3% of flowEquity SharesSEBI:1e24ce7934bbfca3513af93bd36fce00ef89c593
2,130 shares@ ₹817.63240.3% of flowEquity SharesSEBI:6dbac5daa432aee9d174483ec7a80eb19493328e
10,000 shares@ ₹798.03590.0000% mcap20.6% of flowEquity SharesSEBI:4bf1960a8f5529cb07da05fd6078968d37648aa0
62,485 shares@ ₹705.97640.0003% mcap6.6% of flowEquity SharesSEBI:6573006c562ef7f9a82523a930445342a09ddf84
44,127 shares@ ₹698.95740.0002% mcap79.4% of flowEquity SharesSEBI:b69ef01edabcd3e44c4031db41df85f4c13963e7
41,460 shares@ ₹711.33860.0002% mcap4.4% of flowEquity SharesSEBI:eedfe13afb65948e77c5a7c1afe98ec985a136a1
51,700 shares@ ₹708.83150.0002% mcap5.5% of flowEquity SharesSEBI:7de2a830c5b6ad155912f4ef013a6ec89cc95167
110,396 shares@ ₹705.17220.0005% mcap11.6% of flowEquity SharesSEBI:a9946aa4aa4870d865f524d61f3d9d21c80dbd99
58,287 shares@ ₹706.36690.0002% mcap6.1% of flowEquity SharesSEBI:893c4528dac94b912f2f7f820dec7ffdff924e37
89,055 shares@ ₹713.41710.0004% mcap9.4% of flowEquity SharesSEBI:c0a5addce37a60b0040a48dc63df29c90ace5fe8
267,692 shares@ ₹713.50560.0011% mcap28.4% of flowEquity SharesSEBI:1bd39aae0854bee3d56fe9b8882da90259ee5d5b
17,467 shares@ ₹709.72540.0001% mcap100.0% of flowEquity SharesSEBI:925272469dffc39a0062422c14414c118b0391ac
5,803 shares@ ₹718.4830.0000% mcap0.6% of flowEquity SharesSEBI:df511b5521e10042ae250acde6a2639190f7d31d
258,521 shares@ ₹719.41650.0011% mcap27.5% of flowEquity SharesSEBI:13c26024590b0e6df53dde1558597e1a45c2687d
About Himanshu Jayantbhai Shah
Himanshu Jayantbhai Shah is an executive at Eris Lifesciences Limited, an Indian company specializing in the pharmaceutical sector. In his role, he is responsible for managing operations and the company's strategy. Eris Lifesciences is known for its commitment to innovation and quality in the healthcare field.